References
- PATHSummary of Stability Data for Licensed VaccinesSeattle, WAWorking in Tandem Ltd2012
- KumruOSJoshiSBSmithDEMiddaughCRPrusikTVolkinDBVaccine instability in the cold chain: mechanisms, analysis and formulation strategiesBiologicals201442523725924996452
- ChenDZehrungDDesirable attributes of vaccines for deployment in low-resource settingsJ Pharm Sci20131021293323136115
- ZhangJPritchardEHuXStabilization of vaccines and antibiotics in silk and eliminating the cold chainProc Natl Acad Sci U S A201210930119811198622778443
- World Health OrganizationThe controlled temperature chain (CTC): frequently asked questionsGenevaWHO Available from: http://www.who.int/immunization/programmes_systems/supply_chain/resources/Controlled-Temperature-Chain-FAQ.pdfAccessed May 24, 2018
- World Health OrganizationWhat is a controlled temperature chain (CTC)?GenevaWHO Available from: http://www.who.int/immu-nization/programmes_systems/supply_chain/resources/WHO_CTC_Infographic.pdf?ua=1Accessed May 24, 2018
- WangWLyophilization and development of solid protein pharmaceuticalsInt J Pharm20002031–216010967427
- KasperJCWinterGFriessWRecent advances and further challenges in lyophilizationEur J Pharm Biopharm201385216216923751601
- ZipurskySDjingareyMHLodjoJCOlodoLTiendrebeogoSRonveauxOBenefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in BeninVaccine201432131431143524559895
- ZipurskySBoualamLCheikhDOAssessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in ChadVaccine201129345652565621699946
- ClausiACummiskeyJMerkleySCarpenterJFBraunLJRandolphTWInfluence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccineJ Pharm Sci200897125252526218398901
- ClausiALMerkleySACarpenterJFRandolphTWInhibition of aggregation of aluminum hydroxide adjuvant during freezing and dryingJ Pharm Sci20089762049206117879291
- LiXThakkarSGRuwonaTBWilliamsRO3rdCuiZA method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitutionJ Control Release2015204385025735896
- MoraisARAlencar ÉdoNXavier JúniorFHFreeze-drying of emulsified systems: a reviewInt J Pharm20165031–210211426943974
- ChristensenDFogedCRosenkrandsINielsenHMAndersenPAggerEMTrehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-dryingBiochim Biophys Acta2007176892120212917555704
- IyerVCayatteCMarshallJDFeasibility of freeze-drying oil-in-water emulsion adjuvants and subunit proteins to enable single-vial vaccine drug productsJ Pharm Sci201710661490149828259764
- WHOGlobal tuberculosis control report 20162016
- AndersenPDohertyTMThe success and failure of BCG – implications for a novel tuberculosis vaccineNat Rev Microbiol20053865666216012514
- CheckleyAMMcShaneHTuberculosis vaccines: progress and challengesTrends Pharmacol Sci2011321060160621803435
- Abu-RaddadLJSabatelliLAchterbergJTEpidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProc Natl Acad Sci U S A200910633139801398519666590
- BertholetSIretonGCKahnMIdentification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosisJ Immunol2008181117948795719017986
- BertholetSIretonGCOrdwayDJA defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosisSci Transl Med201025353ra74
- OrrMTFoxCBBaldwinSLAdjuvant formulation structure and composition is critical for the development of an effective vaccine against tuberculosisJ Control Release2013172119020023933525
- OrrMTKramerRMBarnesL5thElimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilizationJ Control Release2014177202624382398
- ChanMYDowlingQMSivananthanSJKramerRMParticle sizing of nanoparticle adjuvant formulations by dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA)Methods Mol Biol2017149423925227718198
- MadduxNRJoshiSBVolkinDBRalstonJPMiddaughCRMultidimensional methods for the formulation of biopharmaceuticals and vaccinesJ Pharm Sci2011100104171419721647886
- ChanMYDutillTSKramerRMLyophilization of adjuvanted vaccines: methods for formulation of a thermostable freeze-dried productMethods Mol Biol2017149421522627718196
- S.I. IncJMP® 11 Design of Experiments GuideCary, NCSAS Institute Inc2014
- SchwartzAMChanMYFedorDMSivananthanSJKramerRMStaining and transfer techniques for SDS-PAGE gels to minimize oil-in-water emulsion adjuvant interferenceMethods Mol Biol2017149427328327718201
- MatthiasDMRobertsonJGarrisonMMNewlandSNelsonCFreezing temperatures in the vaccine cold chain: a systematic literature reviewVaccine200725203980398617382434